CGP 9000: a new orally active, broad-spectrum cephalosporin.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  1976-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.7164/ANTIBIOTICS.29.653PMID 950320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Natural product inspired antibiotics approved for human use - 1943 to 2025.

  2025cites this paper
• A specific and rapid HPLC assay for the determination of cefroxadine in human plasma and its application to pharmacokinetic study in Korean.

  2006cites this paper
• Activity of cefroxadine and cephalexin in urinary tract infections: A double-blind comparative study

  2005cites this paper
• Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis

  2004cites this paper
• [Orally active cephalosporins. I. Synthesis and structure-activity relationships of 7 beta-[2-(R)-amino-2-phenylacetamido]-3-(1H- 1,2,3-triazol-4-yl)alkylthiomethyl-3-cephem-4-carboxylic acid and related compounds].

  1992cites this paper
• Peroral absorption of cefroxadine in patients within the first day after severe trauma: comparison to cefroxadine pharmacokinetics in fasted, healthy volunteers.

  1991cites this paper
• Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.

  1991cites this paper
• Comparison of continuous, constant rate enteral tube feeding in supine patients to bolus food intake in ambulatory, healthy subjects regarding bioavailability of perorally administered cefroxadine.

  1991cites this paper
• In-vitro evaluation of a new oral cephalosporin, cefroxadine (CGP 9000).

  1990cites this paper
• Pharmacokinetics of cefroxadine after infusion to healthy volunteers.

  1990cites this paper
• In vitro investigation of BK-218, a new oral and parenteral cephalosporin

  1990cites this paper
• [Synthetic cephalosporins. V. Synthesis and antibacterial activity of 3-alkylthio-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]cephalosporins and related compounds].

  1989cites this paper
• [Synthetic cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]-3-(1,2,3-triazol-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds].

  1989cites this paper
• Determination of the thermodynamic ionization constants of cefroxadine.

  1987cites this paper
• Synthesis and structure-activity relationships of a new oral cephalosporin, BMY-28100 and related compounds.

  1987cites this paper
• Synthetic cephalosporins. II. The synthesis and oral activity of 7-[R-2-amino-2-(3-chloro-4-hydroxyphenyl)acetamido]-3-methylthio-3- cephem-4-carboxylic acid and related compounds.

  1987cites this paper
• In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin

  1987cites this paper
• In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics

  1987cites this paper
• Beta-lactam antibiotics.

  1986cites this paper
• In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic

  1984cites this paper
• A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection

  1984cites this paper
• Pharmacokinetics of cefroxadin (CGP 9000) in man

  1982cites this paper
• Il Cgp 9000, Antibiotico per Uso Orale, in Urologia: Relazione Clinica

  1982cites this paper
• Solvent drag effect in drug intestinal absorption. I. Studies on drug and D2O absorption clearances.

  1982cites this paper
• Cephalosporin Antibiotics Prepared by Modifications at the C-3 Position

  1982cites this paper
• Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.

  1981cites this paper
• Clinical Pesults of Cefroxadinein Children With Acute Purulent Otitis Media

  1981cites this paper
• 泌尿器科領域におけるCefroxadine (CGP-9000) の使用経験

  1980cites this paper
• Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans

  1980cites this paper
• Cefroxadine (CGP-9000) の大腸菌に対する抗菌作用機作に関する研究

  1980cites this paper
• 新経口Cephalosporin系抗生物質Cefroxadine (CGP-9000) の抗菌力, 吸収, 排泄, 代謝, 臓器移行性および外科臨床応用について

  1980cites this paper
• 新経口Cephalosporin剤Cefroxadine (CGP-9000) の in vitro, in vivo抗菌作用

  1980cites this paper
• Cefroxadine (CGP-9000) の基礎的, 臨床的検討

  1980cites this paper
• 新しい経口用セファロスポリン系抗生物質Cefroxadine (CGP-9000) に関する細菌学的研究

  1980cites this paper
• Governmental toxicology regulations: an encumbrance to drug research?

  1979cites this paper
• 新広域cephalosporin, Cefotiam (SCE-963) の in vitro および in vivo 抗菌作用について

  1979cites this paper
• Effects of subminimal inhibitory concentrations of antibiotics in experimental infections.

  1979cites this paper
• Description and classification of the newer cephalosporins and their relationships with the established compounds.

  1979cites this paper
• SCE-963, a New Broad-Spectrum Cephalosporin: In Vitro and In Vivo Antibacterial Activities

  1978cites this paper